Taevas
United Arab EmiratesPersonal Care & Beauty
Product Registration
Market Access for Product-Registration in United Arab Emirates
Navigating the complex global regulatory landscape requires a strategic approach to market access. Taevas Life Sciences ensures your registered products achieve optimal patient access and commercial success across diverse international markets, transformi
Market
Global
Industry
Product-Registration
Regulator
International Health Authorities
Timeline
4-6 weeks (Initial Assessment)
Deliverables
Strategy Report, Access Roadmap, Evidence Plan
What We Deliver
6 Pillars of Global Market Access
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory & P&R Landscape Analysis
We conduct comprehensive analyses of the specific regulatory requirements and pricing & reimbursement (P&R) environments across target global markets. This foundational understanding informs a robust market access strategy.
Identify key market access hurdles
Assess P&R mechanisms and trends
How It Works
How We Ensure Global Market Access for Your Registered Products
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Strategic Alignment
We begin with a deep dive into your product's profile, target markets, and commercial objectives. This phase establishes a clear scope and aligns our strategy with your overarching business goals.
Market Snapshot
Market Overview: Global + Product-Registration
Regulatory Divergence & Harmonization Challenges
Despite efforts towards harmonization, global regulatory requirements and P&R frameworks remain highly fragmented. Navigating these differences effectively is critical for product registration success and subsequent market access.
The Imperative of Value-Based Access
Increasingly, regulatory approval alone is insufficient. Payers worldwide demand robust evidence of a product's real-world clinical effectiveness and economic value to grant reimbursement, shifting the focus to value-based access models.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining target markets, P&R strategies, and actionable plans for optimal access.
Value Dossier & HTA Submission Templates
Tailored dossiers and support for submissions to health technology assessment bodies and payers globally.
Pricing & Reimbursement Landscape Analysis
Detailed reports on market-specific pricing benchmarks, reimbursement pathways, and payer requirements.
Stakeholder Engagement & Advocacy Plan
A strategic roadmap for identifying, engaging, and influencing key decision-makers and influencers.
Who This Is For
Use Cases
Orphan Drug
Expediting Orphan Drug Access in Multiple Regions
A biotech company with a newly registered orphan drug needed to secure rapid market access across North America, Europe, and Asia. Taevas developed a tiered pricing strategy and country-specific value dossiers, navigating diverse P&R systems.
Outcome
Achieved market access in 10+ countries within 18 months, exceeding initial revenue projections.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Don't let regulatory approval be the final hurdle. Partner with Taevas Life Sciences to transform your registered products into global market successes.
Accelerated Patient Access
Maximized Commercial Value
Reduced Market Entry Risks
Strategic Global Expansion